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Abstract
Background: Many of the currently used models of bacterial meningitis have limitations due to direct inoculation
of pathogens into the cerebrospinal fluid or brain and a relatively insensitive assessment of long-term sequelae. The
present study evaluates the utility of a Streptococcus (S.) suis intranasal infection model for the investigation of
experimental therapies in meningitis.
Methods: We examined the brains of 10 piglets with S. suis meningitis as well as 14 control piglets by histology,
immunohistochemistry and in-situ tailing for morphological alterations in the hippocampal dentate gyrus and
microglial activation in the neocortex.
Results: In piglets with meningitis, the density of apoptotic neurons was significantly higher than in control piglets.
Moreover, scoring of microglial morphology revealed a significant activation of these cells during meningitis. The
slight increase in the density of dividing cells, young neurons and microglia observed in piglets suffering from
meningitis was not statistically significant, probably because of the short time frame between onset of clinical signs
and organ sampling.
Conclusions: The morphological changes found during S. suis meningitis are in accordance with abnormalities in
other animal models and human autopsy cases. Therefore, the pig should be considered as a model for evaluating
effects of experimental therapeutic approaches on neurological function in bacterial meningitis.
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Background
Streptococcus (S.) suis is an important pathogen in veter-
inary medicine. Prevention and treatment of S. suis
infections contribute substantially to the high rate of
antibiotic consumption in the pig producing industry
[1]. More than 50% of the cases in pigs occur below the
age of 12 weeks [2]. S. suis can also affect humans.
Transmission to humans usually occurs by close contact
with sick or asymptomatic carrier pigs or contaminated
food. Most human infections are sporadic, but outbreaks
took place particularly in Southeast Asia. S. suis is the
most frequent cause of human bacterial meningitis in
pork-consuming and pig-breeding countries in this area
[3]. Both in pigs and humans, S. suis can cause meningi-
tis, septicemia, endocarditis, arthritis, and septic shock,
with a high mortality. Meningitis and septicemia are the
most frequent clinical disease entities in humans [4].
The fatality rate in adult humans is approximately 13%,
and the most frequent long-term sequelae are hearing
loss (39%) and vestibular dysfunction (23%) [5].
Many animal models used to study the pathophysiology
of bacterial meningitis and to assess the effect of experi-
mental therapeutic approaches on outcome have two
main shortcomings: 1. Bacteria are often injected directly
into the cerebrospinal fluid (CSF) or brain [6–9], because
with few exceptions [10], intranasal or intravenous modes
of administration of bacteria do not cause meningitis in
rates high enough to be suitable for experimental studies.
2. The neuropsychological assessment of long-term seque-
lae, particularly in mice, but also in rats, is not very
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sensitive to detect deficits. S. suis meningitis in pigs as a
model may overcome these shortcomings, since infection
usually is induced by intravenous injection or intranasal
inoculation of S. suis which closely mimics the conditions
in human disease [11]. From the bloodstream, these path-
ogens most likely enter the CSF via the choroid plexus
[12]. In terms of size, the pig brain corresponds better to
humans compared to the rodent brain. Moreover, genet-
ics, anatomy and physiology of the pig are closely related
to humans [13]. For the assessment of long-term motor
and neuropsychologic sequelae in pigs, several sensitive
and valid test batteries are available [14, 15]. For these rea-
sons, the pig model of S. suis meningitis may be preferable
to all rodent models to study the effect of experimental
therapeutic approaches on neurological function in
meningitis.
Morphological abnormalities in human autopsy cases
and radiological studies as well as animal models of bac-
terial meningitis are well characterized [7, 8, 16–23].
The present study further evaluates the utility of the pig-
let model for the study of experimental therapies in bac-
terial meningitis. We aimed at assessing whether the
morphological alterations seen in the brains of piglets
with S. suis meningitis are comparable to the abnormal-
ities observed in human autopsy cases and in rodent
models of bacterial meningitis.
Methods
S. suis infection model
In this study, brains of piglets from partially published ex-
periments were analysed [24, 25]. Briefly, 35 German
Landrace piglets purchased from one breeder at ages of 4
to 9 weeks, free of suilysin (sly)+, muramidase-released
protein (mrp)+, extracellular factor (epf) + and capsular
serotype (cps)2+ S. suis strains, were intranasally infected
with approximately 1 × 109 colony forming units (CFU) S.
suis serotype 2 strain 10 (sly+, mrp+, epf+) after decreasing
the colonization resistance of the nasal mucosa by intrana-
sal treatment with 1% acetic acid [26]. Piglets were cared
for in accordance with the principles outlined in the Euro-
pean Convention for the Protection of Vertebrate Animals
Used for Experimental and Other Scientific Purposes. The
animal experiments were approved by the Committee on
Animal Experiments of the Lower Saxony State Office for
Consumer Protection, Food Safety and Animal Protection
(permit no. 33.14–42,502–04-12/0965 and 33.9–42,502–
04-12/0965). In the case of high fever (≥ 40.5 °C), apathy
and anorexia persisting over 36 hours (h) as well as in all
cases with clinical signs of acute polyarthritis or severe
meningitis, animals were anaesthetized with 2 mg/kg aza-
peron (Stresnil; Janssen, Neuss, Germany) and 10 mg/kg
ketamine-hydrochloride (Ursotamin; Serumwerk, Bern-
burg, Germany) intramuscularly. Thereafter, they were
sacrificed by injection of 100 mg/kg pentobarbital sodium
(Release; Wirtschaftsgenossenschaft deutscher Tierärzte
eG, Garbsen, Germany) into the marginal ear vein. The
interval between infection and termination of the experi-
ment for animals with meningitis is depicted in Table 1.
Out of 35 infected piglets, 10 animals developed men-
ingitis and were classified as experimental group. A total
of 14 piglets that showed no inflammation in the CNS
and no gross morphological abnormalities in all organs
investigated, or had only histopathological alterations in
one organ other than the brain, and in that organ, S. suis
was not detected, were included in the control group.
Animals were excluded from the analysis, as they
Table 1 Clinical data of piglets with meningitis
animal
no.
lesiona intensity
of the
lesion
semiquantitative
bacterial loadb in
CSF
semiquantitative
bacterial loadb in
brain swabs
age at time point
of infection (in
weeks)
interval between infection
and first signs of sickness
(days)c
interval between infection
and termination of the
experiment (days)
1 A mild +++ +++ 4 1 1.5
2 B; D severe +++ + 4 1.5 3
3 B; D severe +++ ++ 4 4 5.5
4 B severe +++ + 7 2.5 3.5
5 B severe – +++ 9 1 2.5
6 A mild ++ ++ 9 1 3
7 B severe ++ + 9 6.5 7.5
8 C severe +++ +++ 9 2.5 3.5
9 B severe +++ + 9 6.5 7.5
10 B severe – +++ 9 1 2.5
aA = focal purulent meningitis
B = diffuse purulent meningitis
C =multi-focal purulent meningitis
D = encephalitic involvement of the brain tissue
bbacterial load: + < 50 colonies; ++ ≥50 colonies; +++ ≥500 colonies per plate; − no detection of the infection strain
cfirst signs of sickness such as fever (≥ 40.2 °C), apathy, convulsions, lameness and anorexia
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showed histopathological alterations in more than one
organ and/or bacteria were detected in the respective or-
gan(s). These piglets had pleuritis, peritonitis, synoviali-
tis, splenitis, hepatitis, pneumonia or endocarditis. The
14 control piglets were screened negative for S. suis
serotype 2 strain 10 (with exception of the tonsils). All
surviving piglets including the control piglets were killed
14–15 days post infection (dpi). Thereafter, each animal
was autopsied according to the same protocol, which
included predefined collection of samples for histological
and bacteriological investigations. Purulent inflamma-
tions were scored by blinded investigators as described
previously [26]. The following lesions were detected in
the piglets by histological investigations (n = 35; some
piglets had more than one histopathological lesion):
meningitis (n = 10, 28.6%; of which 2 piglets showed also
encephalitic involvement of the brain tissue), pleuritis or
peritonitis (n = 7, 20.0%), synovialitis (n = 5, 14.3%),
splenitis or hepatitis (n = 8, 22.9%), pneumonia (n = 15,
42.9%) and endocarditis (n = 1, 2.9%). Eight piglets
(22.9%) did not develop histopathological lesions (with
exception of a minimal accumulation of neutrophils in
the red pulp of the spleen). For assessment of the semi-
quantitative bacterial loads 50 μl CSF and the brain swab
of each animal were plated on Columbia sheep blood
agar and incubated for 24 h at 37 °C (+ < 50 colonies; +
+ ≥50 colonies; +++ ≥500 colonies per plate).
Brain sections of the hippocampal formation, the
frontal cortex and the cerebellum of 10 piglets with
meningitis confirmed by histopathological analysis and
14 control piglets from the same infection experiments
were used for further analysis by histology, immunohis-
tochemistry and in-situ tailing. Inflammation of menin-
ges and brain tissue was evaluated by haematoxylin and
eosin (HE) and chloroacetate esterase (CAE) staining of
2 μm sections from the frontal cortex, the cerebellum
and the hippocampal formation. HE stained sections
were also used to detect ischemic lesions.
Immunohistochemistry and in-situ tailing
Two μm thick brain sections of the hippocampal forma-
tion were deparaffinised, microwaved (5 × 3 min; 800 W),
incubated in citric acid buffer (10 mmol/L, pH 6.0) for
10 min and then blocked with 10% fetal calf serum (FCS)
in phosphate-buffered saline (PBS) for 30 min. All primary
antibodies were applied at the concentrations indicated
below and incubated overnight at 4 °C in PBS. Brain slices
were stained for the detection of proliferating cells with a
monoclonal mouse anti-PCNA (proliferating cell nuclear
antigen) antibody (dilution 1:200; Chemicon, Temecula,
CA), microglia were detected using a polyclonal rabbit
anti-Iba-1 (ionized calcium binding adaptor molecule 1)
(1:400, Wako, Neuss, Germany) antibody. Astrocytes were
visualized by a polyclonal rabbit anti-GFAP (glial fibrillary
acidic protein) antibody (1:1000; Dako, Hamburg,
Germany), and axonal injury was investigated with a
monoclonal mouse antibody against APP (amyloid beta
precursor protein) (1:2000; Chemicon) as described previ-
ously by Tauber et al. [27]. For staining of young
post-mitotic neurons an antibody directed against calreti-
nin was used (1:1000, Swant, Bellinzona, Switzerland)
[28]. For detection of S. suis antigen brain sections were
blocked with 2% bovine serum albumin (BSA) plus 0.2%
Triton X-100 in PBS for 20 min and then incubated with
a rabbit anti-S. suis antibody (1:250). Secondary biotinyl-
ated sheep anti-mouse antibodies (1:200; Amersham,
Buckinghamshire, UK) or biotinylated donkey anti-rabbit
antibodies (1200; GE Healthcare, Buckinghamshire, UK)
diluted in PBS, followed by addition of avidin−biotin per-
oxidase complex (Vector Laboratories, Burlingame, CA),
and diaminobenzidine (Roche, Mannheim, Germany) as
chromogenic substrates were used for visualization. Bind-
ing of the APP antibody was visualized using the alkaline
phosphatase/anti-alkaline phosphatase method with New
Fuchsin as the chromogenic substrate. Brain sections were
counterstained with hemalum (Merck, Darmstadt,
Germany). Isotypic antibodies and brain sections incu-
bated with secondary antibodies in the absence of primary
antibodies served as controls as described by Tauber et al.
[27]. After incubation with primary and secondary anti-
bodies samples were washed with PBS.
Apoptotic neurons in the dentate gyrus of the hippo-
campal formation [7, 8, 20, 27] and granulocytes in men-
ingeal infiltrates [29, 30] were identified by in-situ tailing
(IST) and morphology (condensed, shrunken nuclei,
condensed and shrunken eosinophilic cytoplasm) [31].
The sections were counterstained with nuclear fast
red-aluminiumhydroxide (Roche, Mannheim, Germany).
Representative results of stained brain sections are
shown in Fig. 1.
Microscopy and statistical analysis
To quantify cells in the dentate gyrus, only immunoreac-
tive cells in the granule cell layer and the subgranular zone
(SGZ) were counted [27]. Analysis Software Imaging Sys-
tem (microscope BX51; Olympus; software AnalySIS 3.2;
Soft Imaging System GmbH, Münster, Germany) was used
to measure the area of the dentate granule cell layer. For
analysis of microglial activation morphology, we followed
the activation steps identified and described by Kreutzberg
[32] (0 = fully resting microglia with multiple branches; 1
=mix between resting and mildly activated microglia,
demonstrating shortened processes with increased thick-
ness; 2 =mildly activated microglia with shortened
processes with increased thickness; 3 =mix between
mildly and strongly activated ameboid microglia without
processes; 4 = ameboid microglia without processes) in
the neocortical layers I-III.
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Data were expressed as medians and scatter dot plots
and compared by two-tailed Mann-Whitney U-test. Stat-
istical analyses were carried out using GraphPad Prism
(GraphPad 6 Software, San Diego, CA, USA). Probabil-
ities lower than 0.05 were considered statistically signifi-
cant (* p < 0.05; *** p < 0.001).
Results
In this study the brains of piglets which had been in-
fected intranasally with S. suis serotype 2 strain 10 were
analysed for leukocyte infiltration, microglial and astro-
cyte density, ischemia, axonal injury, neuronal apoptosis
and neural proliferation in the dentate gyrus of the hip-
pocampal formation as well as microglial activation in
the neocortical layers I-III. At autopsy, piglets showed
severe diffuse purulent meningitis (5 cases) (Fig. 1a),
severe diffuse purulent meningitis with encephalitic in-
volvement of the brain tissue (2 cases) (Fig. 1b), severe
multi-focal purulent meningitis (1 case) and mild focal
purulent meningitis (2 cases). Axonal damage and
ischaemic injury was found in one case (Fig. 1c and d,
respectively). Piglets that developed meningitis showed
typical signs of illness starting from day 1 until 6.5 days
post infection (median time 2 days). Depending on the
severity of clinical signs, the piglets were euthanized
0.5–2 days (median time 1.25 days) after onset of the
first clinical signs of illness. In the meningitis group S.
suis was detected by bacteriological cultures and PCR
Fig. 1 Histology, immunohistochemistry and in-situ tailing of brain sections from piglets suffering from S. suis meningitis. Chloroacetate esterase
(CAE)-staining of a frontal cortex section of a piglet suffering from meningitis (a; animal no. 10) or haemorrhagic meningoencephalitis (b; animal
no. 3). Neutrophilic granulocytes and some monocytes are stained violet. Axonal damage was visualized by an anti-amyloid beta precursor
protein (APP) antibody (brown) (c; animal no. 3) and was observed only in one piglet. Ischaemic injuries were visualized by H&E staining and also
found only in one animal (d; animal no. 3). The densities of apoptotic leukocytes in meningeal infiltrates (e; animal no. 4) and granule cells in the
hippocampal dentate gyrus (f; animal no. 5) were assessed by in-situ tailing (dark violet) and morphology. Proliferation of neural progenitor cells
in the dentate gyrus was detected by staining of the proliferating cell nuclear antigen (PCNA) (brown) (g; animal no. 4). Young neurons were
stained with an anti-calretinin antibody (brown) (h; animal no. 5). Microglia were detected by an anti-ionized calcium binding adaptor molecule
1 (Iba-1) antibody (brown) (animal no. 9). Microglia were slightly activated in the dentate gyrus (i) and highly activated (j) in close proximity to
the CSF compartments. Astrocytes were stained with an anti-glial fibrillary acidic protein (GFAP) antibody (brown) (k; animal no. 4). The horizontal
bars indicate 100 μm (a-c), 500 μm (d), 200 μm (e), 20 μm (f) and 50 μm (g-k)
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analysis in 8 out of 10 CSF samples and in all brain
swabs (Table 1). The control group consisted of 14
piglets that had been intranasally infected but which
lacked any S. suis-associated lesions in the brain and
were negative for the infection strain in the bacterio-
logical screenings (with exception of the tonsils).
The hippocampal formations of the piglets were
analysed by immunohistochemistry and in-situ tailing
for morphological alterations. An increased density of
apoptotic neurons in the hippocampal dentate gyrus
(median = 4.45/mm2) in piglets with meningitis was
measured compared to control piglets without signs of
CNS inflammation (median = 1.14/mm2) (p = 0.017)
(Fig. 2a). Proliferation in the granule cell layer and the
subgranular zone of the hippocampal dentate gyrus as a
sign of regeneration, analysed by counting cells positive
for PCNA, was slightly increased in the meningitis group
but did not differ significantly from the control group (p
= 0.4) (Fig. 2b). A tendency towards an increased neuro-
genesis during meningitis was detectable as assessed by
the density of calretinin-positive cells, but the difference
also did not reach statistical significance (p = 0.19) (Fig. 2c).
Scoring of the morphology of microglia revealed a strong
activation of these cells in the meningitis group and only a
slight activation in the control group in layer I-III in the
neocortex (Fig. 2d) (p = 0.0008). In line with these results,
strong microglial activation was seen close to the CSF com-
partments in piglets suffering from meningitis (Fig. 1j).
However, the number of microglial cells did not differ sig-
nificantly in both groups (Fig. 2e) (p = 0.44). We did not see
astrocytosis in the hippocampal dentate gyrus (p = 0.99, pig-
lets with meningitis versus control piglets) (Fig. 2f). In the
meningitis group, S. suis and S. suis antigens were detected
by a S. suis-specific antibody in meningeal infiltrates (Fig. 3a)
and in the cytoplasm of phagocytes, respectively (Fig. 3b).
Discussion
In the present study we aimed at assessing whether the
morphological alterations seen in the brains of piglets
with S. suis meningitis are comparable to the abnormal-
ities observed in human autopsy cases and in rodent
models of bacterial meningitis. All piglets analysed in
this study were infected intranasally with S. suis. Piglets
which were selected as controls did not show
infection-associated lesions of the CNS when investi-
gated histopathologically and were negative in the bac-
teriological screening for the infection strain in CSF as
well as in punctures of the tarsal joints, brain, peritoneal,
pleural, and pericardial cavities, cranial lobe of the lung,
liver and spleen. Animals were excluded from the
analysis as they showed histopathological alterations in
more than one organ other than the brain and/or
Fig. 2 Comparison of densities of immunoreactive cells and morphological scoring of microglia in 10 piglets suffering from meningitis and
14 control piglets. In sections of the hippocampal dentate gyrus, significantly more apoptotic neurons were found in piglets with meningitis
compared to control piglets (in-situ tailing) (a). No significantly different densities of dividing cells (proliferating cell nuclear antigen (PCNA)
staining) (b), young neurons (calretinin staining) (c), microglia (ionized calcium binding adaptor molecule 1 (Iba-1) staining) (e) and astrocytes
(glial fibrillary acidic protein (GFAP) staining) were detected (f). Morphological scoring of Iba-1 stained cells in the neocortex revealed a
significantly stronger activation of microglia in piglets with meningitis (d). *p ≤ 0.05; ***p≤ 0.001
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because bacteria were detected in the respective or-
gan(s). All piglets used in the experiments were of simi-
lar age and the same breed, but from different litters. It
is known that a substantial within-breed variability exists
in pigs [33] which may explain the different disease out-
comes. Moreover, the course of the disease depends on
the immune status of the animals, which is shaped by
genetics, transferred maternal immunity (at least in the
first weeks after birth), health status and environmental
factors [34, 35].
Meningitis is a typical feature of S. suis CNS infec-
tions, whereas encephalitis (i.e., involvement of brain tis-
sue) is described less frequently. In the present study, we
observed meningitis in 8 out of 10 piglets with infection
of the CNS and in two out of 10 piglets a strong menin-
goencephalitis. Similarly, in humans infected with S. suis,
the main pathology is meningitis followed by sepsis, arth-
ritis, endocarditis, and endophthalmitis [5]. Encephalitic in-
volvement of the brain parenchyma was described less
frequently in patients [36, 37]. In an experimental model
using the Chinese S. suis serotype 2 strain SC19, intranasal
inoculation of pigs resulted in meningoencephalitis in all
animals with CNS infection [38]. Similarly, Sanford [39]
reported meningoencephalitis and meningoencephalomye-
litis in all 53 investigated cases of naturally occurring S. suis
CNS infections in pigs. In contrast, others found only men-
ingitis after experimental infection [40–43]. Involvement of
the brain tissue may depend on serotype [44], strain and
(in experimental infections) on study design.
Inflammation of the CNS was observed in 10 out of 35
piglets (28.6%) after intranasal inoculation of S. suis. In a
murine colonization and infection model, meningitis
was detected only in 1 out of 10 mice (without intrana-
sal pretreatment with acetic acid) and in none of 32
mice in which the colonization resistance of the nasal
mucosa was reduced by intranasal administration of 1%
acetic acid, even though the same S. suis strain and a five
times higher infection dose (5 × 109 CFU/mouse) was
used [45]. In a murine pneumococcal infection model
meningitis rates of 50% were observed after intranasal
administration of hyaluronidase prior infection [10].
In most animal models, and in human autopsy cases,
neuronal injury and neural repair as well as microglial
proliferation and astrocytosis are frequently detectable
in the hippocampal formation during meningitis and
meningoencephalitis [7, 8, 17, 20, 27, 46–50]. Therefore,
we focused on morphological changes in this brain
region during CNS infection with S. suis. In piglets suf-
fering from meningitis, we observed an increase in apop-
totic neurons in the dentate gyrus compared to control
piglets. These results are in line with morphological
abnormalities in a rabbit model of pneumococcal menin-
gitis [8, 47], in neonatal and adult rat models [7, 51] and
in human autopsy cases [20]. However, the number of
apoptotic cells was in general lower in the pig model
(meningitis group: 0–30 apoptotic cells/mm2 vs. control
group: 0–3 apoptotic cells/mm2) in contrast to the
rabbit model (meningitis group: 227 (99/339) apoptotic
cells/mm2 vs. control group: 41 (37/45) apoptotic cells/
mm2, [median (25./75. quartile)]) [47] but comparable
with a mouse model of pneumococcal meningitis (men-
ingitis group: 71 ± 29 apoptotic cells/mm2 vs. control
group: 37 ± 18 cells/mm2) [52]. The density of apoptotic
dentate granular cells in our piglet model was similar to
the density of neuronal apoptosis in human autopsy
cases after death from meningitis [20]. Cytotoxic activity
of the secreted cytolysin suilysin of S. suis may directly
induce neuronal injury as demonstrated by Stringaris et
al. for pneumolysin [53], the highly homologous protein
of S. pneumoniae [54]. A further well described mechan-
ism involved in neuronal damage is the activation of
microglial cells. Different stimuli such as CpG-DNA
[55]; LPS [56, 57], Pam3CSK4 [58] or beta-Amyloid [59,
60] were shown to activate microglia, causing neuronal
damage. In addition, the gram-positive cell wall can acti-
vate microglia [61]. Scoring of the microglial morph-
ology revealed a statistically significant activation of
microglia in the meningitis group (Fig. 2d). However, we
Fig. 3 Detection of S. suis and S. suis antigens in brain sections of piglets with meningitis. S. suis and S. suis antigens (brown) were visualized by a
S. suis-specific antibody in meningeal infiltrates as indicated by arrows (animal no. 5) (a) and in the cytoplasm of phagocytes (animal no.2) (b).
The horizontal bars indicate 20 μm
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detected only a slight increase in microglial cell numbers
in piglets with meningitis even though increased inflam-
mation causes microglial proliferation in the human
CNS [27, 48].
In the present study, we observed a tendency towards
increased proliferation and neuronal differentiation dur-
ing S. suis CNS infection as signs of regeneration. In
humans, significant proliferation of progenitor cells in
the hippocampal dentate granule cell layer and subgra-
nular zone was observed during bacterial meningitis
[17], septic metastatic encephalitis [49] and fungal men-
ingoencephalitis [48]. Different animal models of
pneumococcal CNS infection revealed similar results:
neurogenesis peaked at day 2 post infection, and the dif-
ference between infected and uninfected mice reached
statistical significance at day 6 after intracerebral infec-
tion (measured by density of BrdU-labeled cells in the
subgranular layer of the dentate gyrus). Likewise, neuro-
genesis was significantly increased in rabbits 24 h after
intracisternal infection with pneumococci [47] and in
rats 7 days post infection [62]. In contrast to the mouse,
rat and rabbit models [7, 47, 62–64], piglets were in-
fected by intranasal inoculation which reflects the nat-
ural route of infection and were not treated with
antibiotics.
The lack of significant changes in regard to neuronal
proliferation and differentiation as well as astrocytosis
and number of microglia, which are observed in human
autopsy cases [17, 27, 48], is most likely the result of the
short period of time between the onset of clinical symp-
toms such as fever or apathy and organ sampling. In line
with this hypothesis, axonal damage and ischaemic in-
jury were only observed in one piglet, even though mi-
crobial compounds can cause axonal damage via
stimulation of immune cells [65] and ischaemic injuries
are observed in cases of human meningitis [21]. Piglets
were killed as early as 12–48 h after onset of the first
clinical signs (median interval 30 h) due to reasons of
animal welfare. An antibiotic treatment 12 or 24 h post
infection [20, 47] would be prerequisite for extending
the survival time of piglets, and thus increase the likeli-
hood of detecting more marked morphological changes.
Unlike in rodents, several sensitive and valid test
batteries are available for the assessment of long-term
motor and neuropsychologic sequelae in pigs [14, 15]. In
addition, the pig is considered to be an excellent model
for studying infectious diseases of humans [13, 66].
Genetics, anatomy and physiology of pigs are closely
related to humans. In regard to immunology, the porcine
immune system closely resembles the human immune
system for more than 80% of analyzed immunological
parameters, in stark contrast to mice in which less than
10% of the parameters analyzed were more similar to
humans (see review by Meurens et al. [13]).
Conclusions
The pig model of S. suis meningitis by intranasal infec-
tion appears to be most suitable for studying treatment
options of bacterial meningitis. It has the advantage that
it more closely resembles human meningitis than rodent
models, as underlined by our findings that the brains of
piglets showed the typical morphological alterations
present in human autopsy cases. The lack of statistically
significant differences of some parameters in the present
study may be the consequence of the short duration of
infection and of a mild inflammatory response in the
control group due to the intranasal inoculation of bac-
teria. As shown in rodent infection models [29, 62, 67,
68] an antibiotic treatment can prolong survival and in-
crease the chance of detecting stronger morphological
alterations caused by infectious pathogens. Therefore,
the pig should be considered as a model for evaluating
the effects of experimental therapeutic approaches dur-
ing CNS infections.
Abbreviations
APP: Amyloid beta precursor protein; BSA: Bovine serum albumin;
CAE: Chloroacetate esterase; CFU: Colony forming units; DPI: Days post
infection; CNS: Central nervous system; CSF: Cerebrospinal fluid;
epf: Extracellular factor; FCS: Fetal calf serum; GFAP: Glial fibrillary acidic
protein; h: Hours; HE: Haematoxylin and eosin; Iba-1: Ionized calcium binding
adaptor molecule-1; IST: In-situ tailing; mrp: Muramidase-released protein;
PBS: Phosphate-buffered saline; PCNA: Proliferating cell nuclear antigen;
S: Streptococcus; SGZ: Subgranular zone; sly: Suilysin
Acknowledgements
We thank Cynthia Bunker for language editing.
Funding
This study was supported by the Niedersachsen Research Network on
Neuroinfectiology of the Ministry of Science and Culture of Lower Saxony
(N-RENNT) and the B. Braun-Stiftung. The funding bodies did not influence
the design of the study, collection, analysis, and interpretation of data and in
writing the manuscript.
Availability of data and materials
All data generated or analysed during this study are included in this
published article [and its supplementary information files].
Authors’ contributions
JS contributed to study design, conducted the animal experiments, took
microscopic pictures, analyzed data and drafted the manuscript. SCT
analyzed brain sections and related data and contributed to manuscript
revision. SB conducted all stainings. CGB conducted animal experiments and
contributed to manuscript revision. PVW supported animal experiments and
contributed to manuscript revision. NB supported animal experiments and
contributed to manuscript revision. AB and WB conducted histopathological
analysis and revised the manuscript. AII performed morphological scoring of
microglia and revised the manuscript. RN conceived the study, took
microscopic pictures and drafted the manuscript. All authors read and
approved the final version of the manuscript.
Ethics approval and consent to participate
Piglets were cared for in accordance with the principles outlined in the
European Convention for the Protection of Vertebrate Animals Used for
Experimental and Other Scientific Purposes. The animal experiments were
approved by the Committee on Animal Experiments of the Lower Saxony
State Office for Consumer Protection, Food Safety and Animal Protection
(permit no. 33.14–42,502–04-12/0965 and 33.9–42,502–04-12/0965).
Seele et al. BMC Infectious Diseases  (2018) 18:297 Page 7 of 9
Consent for publication
Not applicable.
Competing interests
The authors declared that they have no competing.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Neuropathology, University Medical Center Göttingen,
Georg-August-University Göttingen, Göttingen, Germany. 2Department of
Geriatrics, Evangelisches Krankenhaus Göttingen-Weende, Göttingen,
Germany. 3Department of Neurology, RWTH University Hospital, Aachen,
Germany. 4Institute for Bacteriology and Mycology, Center for Infectious
Diseases, Faculty of Veterinary Medicine, University Leipzig, Leipzig, Germany.
5Institute for Microbiology, Center for Infection Medicine, University of
Veterinary Medicine Hannover, Hannover, Germany. 6Department of
Physiological Chemistry, Department of Infectious Diseases, University of
Veterinary Medicine Hannover, Hannover, Germany. 7Research Center for
Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine
Hannover, Hannover, Germany. 8Department of Pathology, University of
Veterinary Medicine Hannover, Hannover, Germany. 9Institute of Anatomy,
University of Bern, Bern, Switzerland.
Received: 13 March 2018 Accepted: 22 June 2018
References
1. Seitz M, Valentin-Weigand P, Willenborg J. Use of antibiotics and
antimicrobial resistance in veterinary medicine as exemplified by the
swine pathogen Streptococcus suis. Curr Top Microbiol Immunol. 2016;
398:103–21.
2. Reams RY, Glickman LT, Harrington DD, Bowersock TL, Thacker HL.
Streptococcus suis infection in swine: a retrospective study of 256 cases.
Part I. Epidemiologic factors and antibiotic susceptibility patterns. J Vet
Diagn Investig. 1993;5(3):363–7.
3. van Samkar A, Brouwer MC, Schultsz C, van der Ende A, van de Beek D.
Streptococcus suis meningitis: a systematic review and meta-analysis. PLoS
Negl Trop Dis. 2015;9(10):e0004191. https://www.ncbi.nlm.nih.gov/pubmed/
?term=ostergaard+leib+2010
4. Lun ZR, Wang QP, Chen XG, Li AX, Zhu XQ. Streptococcus suis: an emerging
zoonotic pathogen. Lancet Infect Dis. 2007;7(3):201–9.
5. Huong VT, Ha N, Huy NT, Horby P, Nghia HD, Thiem VD, et al.
Epidemiology, clinical manifestations, and outcomes of Streptococcus suis
infection in humans. Emerg Infect Dis. 2014;20(7):1105–14.
6. Pfister HW, Kodel U, Dirnagl U, Haberl RL, Ruckdeschel G, Einhaupl KM.
Effect of catalase on regional cerebral blood flow and brain edema during
the early phase of experimental pneumococcal meningitis. J Infect Dis.
1992;166(6):1442–5.
7. Leib SL, Kim YS, Chow LL, Sheldon RA, Tauber MG. Reactive oxygen
intermediates contribute to necrotic and apoptotic neuronal injury in an
infant rat model of bacterial meningitis due to group B streptococci. J Clin
Invest. 1996;98(11):2632–9.
8. Zysk G, Bruck W, Gerber J, Bruck Y, Prange HW, Nau R. Anti-inflammatory
treatment influences neuronal apoptotic cell death in the dentate gyrus in
experimental pneumococcal meningitis. J Neuropathol Exp Neurol. 1996;
55(6):722–8.
9. Gerber J, Raivich G, Wellmer A, Noeske C, Kunst T, Werner A, et al. A mouse
model of Streptococcus pneumoniae meningitis mimicking several features
of human disease. Acta Neuropathol. 2001;101(5):499–508.
10. Zwijnenburg PJ, van der Poll T, Florquin S, van Deventer SJ, Roord JJ, van
Furth AM. Experimental pneumococcal meningitis in mice: a model of
intranasal infection. J Infect Dis. 2001;183(7):1143–6.
11. Beineke A, Bennecke K, Neis C, Schroder C, Waldmann KH, Baumgartner W,
et al. Comparative evaluation of virulence and pathology of Streptococcus
suis serotypes 2 and 9 in experimentally infected growers. Vet Microbiol.
2008;128(3–4):423–30.
12. Tenenbaum T, Papandreou T, Gellrich D, Friedrichs U, Seibt A, Adam R,
et al. Polar bacterial invasion and translocation of Streptococcus suis
across the blood-cerebrospinal fluid barrier in vitro. Cell Microbiol.
2009;11(2):323–36.
13. Meurens F, Summerfield A, Nauwynck H, Saif L, Gerdts V. The pig: a model
for human infectious diseases. Trends Microbiol. 2012;20(1):50–7.
14. Naim MY, Friess S, Smith C, Ralston J, Ryall K, Helfaer MA, et al. Folic acid
enhances early functional recovery in a piglet model of pediatric head
injury. Dev Neurosci. 2010;32(5–6):466–79.
15. Rytych JL, Elmore MR, Burton MD, Conrad MS, Donovan SM, Dilger RN, et al.
Early life iron deficiency impairs spatial cognition in neonatal piglets. J Nutr.
2012;142(11):2050–6.
16. Kastenbauer S, Pfister HW. Pneumococcal meningitis in adults: spectrum of
complications and prognostic factors in a series of 87 cases. Brain. 2003;
126(Pt 5):1015–25.
17. Gerber J, Tauber SC, Armbrecht I, Schmidt H, Bruck W, Nau R. Increased
neuronal proliferation in human bacterial meningitis. Neurology. 2009;
73(13):1026–32.
18. Blaser C, Wittwer M, Grandgirard D, Leib SL. Adjunctive dexamethasone
affects the expression of genes related to inflammation, neurogenesis
and apoptosis in infant rat pneumococcal meningitis. PLoS One. 2011;
6(3):e17840.
19. Wippel C, Maurer J, Fortsch C, Hupp S, Bohl A, Ma J, et al. Bacterial cytolysin
during meningitis disrupts the regulation of glutamate in the brain, leading
to synaptic damage. PLoS Pathog. 2013;9(6):e1003380.
20. Nau R, Soto A, Bruck W. Apoptosis of neurons in the dentate gyrus in
humans suffering from bacterial meningitis. J Neuropathol Exp Neurol. 1999;
58(3):265–74.
21. Nau R, Gerber J, Bunkowski S, Bruck W. Axonal injury, a neglected cause of
CNS damage in bacterial meningitis. Neurology. 2004;62(3):509–11.
22. Adams RD, Kubik CS, Bonner FJ. The clinical and pathological aspects of
influenzal meningitis. Arch Pediatr. 1948;65(8):408–41.
23. Adams RD, Kubik CS, Bonner FJ. The clinical and pathological aspects of
influenzal meningitis. Arch Pediatr 1948;65(7):354; passim.
24. Seele J, Beineke A, Hillermann LM, Jaschok-Kentner B, von Pawel-
Rammingen U, Valentin-Weigand P, et al. The immunoglobulin M-
degrading enzyme of Streptococcus suis, IdeSsuis, is involved in
complement evasion. Vet Res. 2015;46:45.
25. Seele J, Hillermann LM, Beineke A, Seitz M, von Pawel-Rammingen U,
Valentin-Weigand P, et al. The immunoglobulin M-degrading enzyme of
Streptococcus suis, IdeSsuis, is a highly protective antigen against serotype
2. Vaccine. 2015;33(19):2207–12.
26. Baums CG, Kaim U, Fulde M, Ramachandran G, Goethe R, Valentin-
Weigand P. Identification of a novel virulence determinant with
serum opacification activity in Streptococcus suis. Infect Immun. 2006;
74(11):6154–62.
27. Tauber SC, Staszewski O, Prinz M, Weis J, Nolte K, Bunkowski S, et al. HIV
encephalopathy: glial activation and hippocampal neuronal apoptosis, but
limited neural repair. HIV Med. 2016;17(2):143–51.
28. Mattiesen WR, Tauber SC, Gerber J, Bunkowski S, Bruck W, Nau R. Increased
neurogenesis after hypoxic-ischemic encephalopathy in humans is age
related. Acta Neuropathol. 2009;117(5):525–34.
29. Nau R, Zettl U, Gerber J, Trostdorf F, Michel U, Bottcher T, et al. Granulocytes
in the subarachnoid space of humans and rabbits with bacterial meningitis
undergo apoptosis and are eliminated by macrophages. Acta Neuropathol.
1998;96(5):472–80.
30. Recher M, Malipiero U, Schaer DJ, Koedel U, Pfister HW, Birchler T, et al.
Inhibition of meningitis-associated neutrophil apoptosis by TNF-alpha
depends on functional PI3-kinase in monocytes. J Leukoc Biol. 2013;
93(2):259–66.
31. Tauber SC, Schlumbohm C, Schilg L, Fuchs E, Nau R, Gerber J. Intrauterine
exposure to dexamethasone impairs proliferation but not neuronal
differentiation in the dentate gyrus of newborn common marmoset
monkeys. Brain Pathol. 2006;16(3):209–17.
32. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS.
Trends Neurosci. 1996;19(8):312–8.
33. SanCristobal M, Chevalet C, Haley CS, Joosten R, Rattink AP, Harlizius B, et al.
Genetic diversity within and between European pig breeds using
microsatellite markers. Anim Genet. 2006;37(3):189–98.
34. Baums CG, Bruggemann C, Kock C, Beineke A, Waldmann KH, Valentin-
Weigand P. Immunogenicity of an autogenous Streptococcus suis bacterin
in preparturient sows and their piglets in relation to protection after
weaning. Clin Vaccine Immunol. 2010;17(10):1589–97.
Seele et al. BMC Infectious Diseases  (2018) 18:297 Page 8 of 9
35. Staats JJ, Feder I, Okwumabua O, Chengappa MM. Streptococcus suis: past
and present. Vet Res Commun. 1997;21(6):381–407.
36. Fauveau L, Mourtada Y, Hazouard E. Meningoencephalitis related-to
Streptococcus suis in a butcher: relevance of occupational questionnaire at
emergency room. Ann Fr Anesth Reanim. 2007;26(9):814–5.
37. Wongjittraporn S, Teerasukjinda O, Yee M, Chung HH. Streptococcus suis
meningoencephalitis with seizure from raw pork ingestion: a case report.
Hawaii J Med Public Health. 2014;73(9 Suppl 1):13–4.
38. Zheng P, Zhao YX, Zhang AD, Kang C, Chen HC, Jin ML. Pathologic analysis
of the brain from Streptococcus suis type 2 experimentally infected pigs.
Vet Pathol. 2009;46(3):531–5.
39. Sanford SE. Gross and histopathological findings in unusual lesions caused
by Streptococcus suis in pigs. II Central nervous system lesions. Can J Vet
Res. 1987;51(4):486–9.
40. Fittipaldi N, Sekizaki T, Takamatsu D, de la Cruz Dominguez-Punaro M, Harel
J, Bui NK, et al. Significant contribution of the pgdA gene to the virulence
of Streptococcus suis. Mol Microbiol. 2008;70(5):1120–35.
41. Fittipaldi N, Sekizaki T, Takamatsu D, Harel J, Dominguez-Punaro Mde L, Von
Aulock S, et al. D-alanylation of lipoteichoic acid contributes to the
virulence of Streptococcus suis. Infect Immun. 2008;76(8):3587–94.
42. de Greeff A, Buys H, Verhaar R, Dijkstra J, van Alphen L, Smith HE.
Contribution of fibronectin-binding protein to pathogenesis of
Streptococcus suis serotype 2. Infect Immun. 2002;70(3):1319–25.
43. Zhang A, Mu X, Chen B, Han L, Chen H, Jin M. IgA1 protease contributes to
the virulence of Streptococcus suis. Vet Microbiol. 2011;148(2–4):436–9.
44. Reams RY, Glickman LT, Harrington DD, Thacker HL, Bowersock TL.
Streptococcus suis infection in swine: a retrospective study of 256 cases.
Part II. Clinical signs, gross and microscopic lesions, and coexisting
microorganisms. J Vet Diagn Investig. 1994;6(3):326–34.
45. Seitz M, Beineke A, Seele J, Fulde M, Valentin-Weigand P, Baums CG. A
novel intranasal mouse model for mucosal colonization by Streptococcus
suis serotype 2. J Med Microbiol. 2012;61(Pt 9):1311–8.
46. Loeffler JM, Ringer R, Hablutzel M, Tauber MG, Leib SL. The free radical
scavenger alpha-phenyl-tert-butyl nitrone aggravates hippocampal
apoptosis and learning deficits in experimental pneumococcal meningitis. J
Infect Dis. 2001;183(2):247–52.
47. Gerber J, Bottcher T, Bering J, Bunkowski S, Bruck W, Kuhnt U, et al.
Increased neurogenesis after experimental Streptococcus pneumoniae
meningitis. J Neurosci Res. 2003;73(4):441–6.
48. Tauber SC, Eiffert H, Kellner S, Lugert R, Bunkowski S, Schutze S, et al.
Fungal encephalitis in human autopsy cases is associated with
extensive neuronal damage but only minimal repair. Neuropathol Appl
Neurobiol. 2014;40(5):610–27.
49. Tauber SC, Bunkowski S, Bruck W, Nau R. Septic metastatic encephalitis:
coexistence of brain damage and repair. Neuropathol Appl Neurobiol. 2011;
37(7):768–76.
50. Leib SL, Kim YS, Ferriero DM, Tauber MG. Neuroprotective effect of
excitatory amino acid antagonist kynurenic acid in experimental bacterial
meningitis. J Infect Dis. 1996;173(1):166–71.
51. Ostergaard C, Leib SL, Rowland I, Brandt CT. Bacteremia causes
hippocampal apoptosis in experimental pneumococcal meningitis. BMC
Infect Dis. 2010;10(1)
52. Zweigner J, Jackowski S, Smith SH, Van Der Merwe M, Weber JR, Tuomanen
EI. Bacterial inhibition of phosphatidylcholine synthesis triggers apoptosis in
the brain. J Exp Med. 2004;200(1):99–106.
53. Stringaris AK, Geisenhainer J, Bergmann F, Balshusemann C, Lee U, Zysk G,
et al. Neurotoxicity of pneumolysin, a major pneumococcal virulence factor,
involves calcium influx and depends on activation of p38 mitogen-activated
protein kinase. Neurobiol Dis. 2002;11(3):355–68.
54. Jacobs AA, Loeffen PL, van den Berg AJ, Storm PK. Identification,
purification, and characterization of a thiol-activated hemolysin (suilysin) of
Streptococcus suis. Infect Immun. 1994;62(5):1742–8.
55. Iliev AI, Stringaris AK, Nau R, Neumann H. Neuronal injury mediated via
stimulation of microglial toll-like receptor-9 (TLR9). FASEB J. 2004;18(2):412–4.
56. Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, et al.
Activation of innate immunity in the CNS triggers neurodegeneration
through a toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A.
2003;100(14):8514–9.
57. Dean JM, Wang X, Kaindl AM, Gressens P, Fleiss B, Hagberg H, et al.
Microglial MyD88 signaling regulates acute neuronal toxicity of LPS-
stimulated microglia in vitro. Brain Behav Immun. 2010;24(5):776–83.
58. Hoffmann O, Braun JS, Becker D, Halle A, Freyer D, Dagand E, et al. TLR2
mediates neuroinflammation and neuronal damage. J Immunol. 2007;
178(10):6476–81.
59. Combs CK, Karlo JC, Kao SC. Landreth GE. Beta-amyloid stimulation of
microglia and monocytes results in TNFalpha-dependent expression of
inducible nitric oxide synthase and neuronal apoptosis. J Neurosci. 2001;
21(4):1179–88.
60. Schutze S, Loleit T, Zeretzke M, Bunkowski S, Bruck W, Ribes S, et al. Additive
microglia-mediated neuronal injury caused by amyloid-beta and bacterial
TLR agonists in murine neuron-microglia co-cultures quantified by an
automated image analysis using cognition network technology. J
Alzheimers Dis. 2012;31(3):651–7.
61. Prinz M, Kann O, Draheim HJ, Schumann RR, Kettenmann H, Weber JR, et al.
Microglial activation by components of gram-positive and -negative
bacteria: distinct and common routes to the induction of ion channels and
cytokines. J Neuropathol Exp Neurol. 1999;58(10):1078–89.
62. Lian D, He D, Wu J, Liu Y, Zhu M, Sun J, et al. Exogenous BDNF increases
neurogenesis in the hippocampus in experimental Streptococcus
pneumoniae meningitis. J Neuroimmunol. 2016;294:46–55.
63. Liebetanz D, Gerber J, Schiffner C, Schutze S, Klinker F, Jarry H, et al. Pre-
infection physical exercise decreases mortality and stimulates neurogenesis
in bacterial meningitis. J Neuroinflammation. 2012;9:168.
64. Barichello T, Fagundes GD, Generoso JS, Dagostin CS, Simoes LR, Vilela MC,
et al. Environmental enrichment restores cognitive deficits induced by
experimental childhood meningitis. Rev Bras Psiquiatr. 2014;36(4):322–9.
65. Tauber SC, Ribes S, Ebert S, Heinz T, Fingerle V, Bunkowski S, et al.
Long-term intrathecal infusion of outer surface protein C from Borrelia
burgdorferi causes axonal damage. J Neuropathol Exp Neurol. 2011;
70(9):748–57.
66. de Greeff A, van Selm S, Buys H, Harders-Westerveen JF, Tunjungputri RN,
de Mast Q, et al. Pneumococcal colonization and invasive disease studied in
a porcine model. BMC Microbiol. 2016;16:102.
67. Gerber J, Pohl K, Sander V, Bunkowski S, Nau R. Rifampin followed by
ceftriaxone for experimental meningitis decreases lipoteichoic acid
concentrations in cerebrospinal fluid and reduces neuronal damage in
comparison to ceftriaxone alone. Antimicrob Agents Chemother. 2003;
47(4):1313–7.
68. Nau R, Wellmer A, Soto A, Koch K, Schneider O, Schmidt H, et al. Rifampin
reduces early mortality in experimental Streptococcus pneumoniae
meningitis. J Infect Dis. 1999;179(6):1557–60.
Seele et al. BMC Infectious Diseases  (2018) 18:297 Page 9 of 9
